Efthymios Deliargyris Cytosorbents Corp (CTSO) insider trading activity

Efthymios Deliargyris is Chief Medical Officer of Cytosorbents Corp. Currently has a direct ownership of 473,025 shares of CTSO, which is worth approximately $501,406. The most recent transaction as insider was on Aug 08, 2025, when has been sold 70,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 473K

17.37% 3M change

15.53% 12M change

Total Value Held $501,406

Efthymios Deliargyris Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 08 2025	BUY Grant, award, or other acquisition	-	70,000 Added 12.89%	473,025 Common Stock
Jan 17 2025	BUY Exercise of in-the-money or at-the-money derivatives securities	$16,233 $1.0 p/Share	16,233 Added 3.87%	403,025 Common Stock
Apr 02 2024	BUY Grant, award, or other acquisition	-	61,000 Added 12.97%	409,433 Common Stock
Dec 13 2023	BUY Open market or private purchase	$30,000 $1.33 p/Share	22,557 Added 6.08%	348,433 Common Stock
Jul 07 2023	BUY Grant, award, or other acquisition	-	55,000 Added 14.22%	331,648 Common Stock
Aug 10 2022	BUY Grant, award, or other acquisition	-	107,000 Added 27.41%	283,384 Common Stock
Apr 12 2021	BUY Grant, award, or other acquisition	$359,600 $8.99 p/Share	40,000 Added 17.94%	183,000 Common Stock

Efthymios Deliargyris

Chief Medical Officer

Princeton, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTSO shares.

Notify only if

Value

Insider Trading

Get notified when an Cytosorbents Corp insider buys or sells CTSO shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cytosorbents Corp

Track Activities on CTSO

Account